Aortic Valve Stenosis
468
71
115
193
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
49 trials with published results (10%)
Research Maturity
193 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
26 terminated out of 468 trials
88.1%
+1.6% vs benchmark
9%
40 trials in Phase 3/4
25%
49 of 193 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 193 completed trials
Clinical Trials (468)
Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation
Patient Quality of Recovery After TAVR With Different Sedation Regimens
Hydra Single-centre Experience - Copenhagen, Denmark
Hydra Registry - Italy Experience
Hydra Registry - UK
EMPagliflozin After Aortic Valve Replacement
Echocardiography Findings in Patients With Myocardial Fibrosis and Severe Aortic Stenosis
Ischemic And Bleeding Risk Assessment After TAVR
COronary Re-engageMent aFter randOm NavitoR alignmenT (COMFORT STUDY)
SAPIEN 3 Ultra System PMCF
Portico and Navitor India Clinical Trial
Platelet Adhesion in the Pathobiology of Aortic Stenosis
Detecting Changes in Arterial Blood Volume and Cardiac Efficiency
Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
Transversus Abdominis Plan (TAP) Block In Transcatheter Aortic Valve Implantation (TAVI)
Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial
Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.
Prolonged Continuous ECG Monitoring Prior to Transcatheter Aortic Valve Implantation